---
title: "[Company Session]Transforming Cancer Immunotherapy by Utilizing a Novel Tumor-Associated..."
image: "https:\/\/i.ytimg.com\/vi\/VzgF72eJSbg\/hqdefault.jpg"
vid_id: "VzgF72eJSbg"
categories: "Science-Technology"
tags: ["生策會","供應鏈","醫療科技展"]
date: "2021-11-29T01:01:15+03:00"
vid_date: "2021-11-22T02:54:03Z"
duration: "PT14M3S"
viewcount: "0"
likeCount: "0"
dislikeCount: "0"
channel: "生策會I.B.M.I"
---
{% raw %}Harada Naozumi<br />CEO, United Immunity<br />Transforming Cancer Immunotherapy by Utilizing a Novel Tumor-Associated Macrophage-Selective Nanoparticulate Delivery System<br /><br />Online matchmaking and meeting tool on B2B platform have already been available since 1 November!<br />To fully exploit business opportunities in this enormous market, please go to our B2B website for more products and services.<br /><br />◆More details:<br />1. Healthcare+ B2B Platform<br /><a rel="nofollow" target="blank" href="https://www.taiwan-healthcare.org/en/">https://www.taiwan-healthcare.org/en/</a><br />2. Japan Session<br /><a rel="nofollow" target="blank" href="https://www.taiwan-healthcare.org/en/latest-news-detail?id=0r2rbtgfbfs98v01">https://www.taiwan-healthcare.org/en/latest-news-detail?id=0r2rbtgfbfs98v01</a><br />3. Find out more in supply chain forum<br /><a rel="nofollow" target="blank" href="https://www.taiwan-healthcare.org/en/events">https://www.taiwan-healthcare.org/en/events</a>{% endraw %}
